vs
AFFILIATED MANAGERS GROUP, INC.（AMG）与科睿唯安（CLVT）财务数据对比。点击上方公司名可切换其他公司
科睿唯安的季度营收约是AFFILIATED MANAGERS GROUP, INC.的1.1倍（$617.0M vs $556.6M），AFFILIATED MANAGERS GROUP, INC.净利率更高（62.4% vs 0.5%，领先61.9%），AFFILIATED MANAGERS GROUP, INC.同比增速更快（6.2% vs -6.9%），AFFILIATED MANAGERS GROUP, INC.自由现金流更多（$254.5M vs $89.2M），过去两年AFFILIATED MANAGERS GROUP, INC.的营收复合增速更高（5.5% vs -0.3%）
Affiliated Managers Group（简称AMG）是一家成立于1993年的美国金融服务企业，总部位于佛罗里达州西棕榈滩。公司股票在纽约证券交易所挂牌交易，代码为AMG，同时是标普400美国中型企业指数的成份股。
科睿唯安是一家英美合资的上市分析服务企业，主要提供订阅制信息服务，覆盖文献计量、科学计量、商业与市场情报领域，同时为医药、生物科技行业提供专利、监管合规相关的竞争分析，也提供商标保护、域名与品牌保护服务，旗下Web of Science产品系列还负责计算学术期刊的影响因子。
AMG vs CLVT — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $556.6M | $617.0M |
| 净利润 | $347.5M | $3.1M |
| 毛利率 | — | 66.8% |
| 营业利润率 | 94.4% | 6.7% |
| 净利率 | 62.4% | 0.5% |
| 营收同比 | 6.2% | -6.9% |
| 净利润同比 | 114.2% | 101.6% |
| 每股收益（稀释后） | $10.87 | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $556.6M | $617.0M | ||
| Q3 25 | $528.0M | $623.1M | ||
| Q2 25 | $493.2M | $621.4M | ||
| Q1 25 | $496.6M | $593.7M | ||
| Q4 24 | $524.3M | $663.0M | ||
| Q3 24 | $516.4M | $622.2M | ||
| Q2 24 | $500.3M | $650.3M | ||
| Q1 24 | $499.9M | $621.2M |
| Q4 25 | $347.5M | $3.1M | ||
| Q3 25 | $212.4M | $-28.3M | ||
| Q2 25 | $84.3M | $-72.0M | ||
| Q1 25 | $72.4M | $-103.9M | ||
| Q4 24 | $162.2M | $-191.8M | ||
| Q3 24 | $123.6M | $-65.6M | ||
| Q2 24 | $76.0M | $-304.3M | ||
| Q1 24 | $149.8M | $-75.0M |
| Q4 25 | — | 66.8% | ||
| Q3 25 | — | 65.0% | ||
| Q2 25 | — | 67.2% | ||
| Q1 25 | — | 65.1% | ||
| Q4 24 | — | 65.7% | ||
| Q3 24 | — | 66.2% | ||
| Q2 24 | — | 67.2% | ||
| Q1 24 | — | 64.9% |
| Q4 25 | 94.4% | 6.7% | ||
| Q3 25 | 68.7% | 7.1% | ||
| Q2 25 | 34.8% | 1.1% | ||
| Q1 25 | 25.5% | -3.5% | ||
| Q4 24 | 52.2% | -9.4% | ||
| Q3 24 | 42.0% | 3.5% | ||
| Q2 24 | 35.6% | -36.9% | ||
| Q1 24 | 50.8% | 0.8% |
| Q4 25 | 62.4% | 0.5% | ||
| Q3 25 | 40.2% | -4.5% | ||
| Q2 25 | 17.1% | -11.6% | ||
| Q1 25 | 14.6% | -17.5% | ||
| Q4 24 | 30.9% | -28.9% | ||
| Q3 24 | 23.9% | -10.5% | ||
| Q2 24 | 15.2% | -46.8% | ||
| Q1 24 | 30.0% | -12.1% |
| Q4 25 | $10.87 | $0.00 | ||
| Q3 25 | $6.87 | $-0.04 | ||
| Q2 25 | $2.80 | $-0.11 | ||
| Q1 25 | $2.20 | $-0.15 | ||
| Q4 24 | $4.95 | $-0.27 | ||
| Q3 24 | $3.78 | $-0.09 | ||
| Q2 24 | $2.26 | $-0.46 | ||
| Q1 24 | $4.14 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $586.0M | $329.2M |
| 总债务越低越好 | $2.7B | $4.3B |
| 股东权益账面价值 | $3.2B | $4.8B |
| 总资产 | $9.2B | $11.1B |
| 负债/权益比越低杠杆越低 | 0.83× | 0.89× |
8季度趋势，按日历期对齐
| Q4 25 | $586.0M | $329.2M | ||
| Q3 25 | $476.1M | $318.7M | ||
| Q2 25 | $361.0M | $362.6M | ||
| Q1 25 | $816.5M | $354.0M | ||
| Q4 24 | $950.0M | $295.2M | ||
| Q3 24 | $1.0B | $388.5M | ||
| Q2 24 | $865.5M | $376.4M | ||
| Q1 24 | $793.4M | $361.8M |
| Q4 25 | $2.7B | $4.3B | ||
| Q3 25 | $2.4B | $4.4B | ||
| Q2 25 | $2.6B | $4.5B | ||
| Q1 25 | $2.6B | $4.5B | ||
| Q4 24 | $2.6B | $4.5B | ||
| Q3 24 | $2.6B | $4.6B | ||
| Q2 24 | $2.5B | $4.6B | ||
| Q1 24 | $2.5B | $4.6B |
| Q4 25 | $3.2B | $4.8B | ||
| Q3 25 | $3.3B | $4.9B | ||
| Q2 25 | $3.2B | $5.0B | ||
| Q1 25 | $3.2B | $5.0B | ||
| Q4 24 | $3.3B | $5.1B | ||
| Q3 24 | $3.3B | $5.5B | ||
| Q2 24 | $3.3B | $5.6B | ||
| Q1 24 | $3.6B | $5.9B |
| Q4 25 | $9.2B | $11.1B | ||
| Q3 25 | $8.9B | $11.2B | ||
| Q2 25 | $8.8B | $11.4B | ||
| Q1 25 | $8.7B | $11.5B | ||
| Q4 24 | $8.8B | $11.5B | ||
| Q3 24 | $8.9B | $12.0B | ||
| Q2 24 | $8.8B | $12.1B | ||
| Q1 24 | $9.0B | $12.5B |
| Q4 25 | 0.83× | 0.89× | ||
| Q3 25 | 0.71× | 0.90× | ||
| Q2 25 | 0.81× | 0.90× | ||
| Q1 25 | 0.82× | 0.90× | ||
| Q4 24 | 0.78× | 0.88× | ||
| Q3 24 | 0.79× | 0.84× | ||
| Q2 24 | 0.76× | 0.83× | ||
| Q1 24 | 0.70× | 0.79× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $256.4M | $159.9M |
| 自由现金流经营现金流 - 资本支出 | $254.5M | $89.2M |
| 自由现金流率自由现金流/营收 | 45.7% | 14.5% |
| 资本支出强度资本支出/营收 | 0.3% | 11.5% |
| 现金转化率经营现金流/净利润 | 0.74× | 51.58× |
| 过去12个月自由现金流最近4个季度 | $967.1M | $365.3M |
8季度趋势，按日历期对齐
| Q4 25 | $256.4M | $159.9M | ||
| Q3 25 | $277.1M | $181.1M | ||
| Q2 25 | $230.8M | $116.3M | ||
| Q1 25 | $208.9M | $171.2M | ||
| Q4 24 | $212.5M | $141.3M | ||
| Q3 24 | $265.2M | $202.9M | ||
| Q2 24 | $245.2M | $126.2M | ||
| Q1 24 | $209.2M | $176.2M |
| Q4 25 | $254.5M | $89.2M | ||
| Q3 25 | $275.9M | $115.5M | ||
| Q2 25 | $229.4M | $50.3M | ||
| Q1 25 | $207.3M | $110.3M | ||
| Q4 24 | $211.4M | $59.1M | ||
| Q3 24 | $264.5M | $126.3M | ||
| Q2 24 | $244.6M | $60.3M | ||
| Q1 24 | $208.2M | $111.8M |
| Q4 25 | 45.7% | 14.5% | ||
| Q3 25 | 52.3% | 18.5% | ||
| Q2 25 | 46.5% | 8.1% | ||
| Q1 25 | 41.7% | 18.6% | ||
| Q4 24 | 40.3% | 8.9% | ||
| Q3 24 | 51.2% | 20.3% | ||
| Q2 24 | 48.9% | 9.3% | ||
| Q1 24 | 41.6% | 18.0% |
| Q4 25 | 0.3% | 11.5% | ||
| Q3 25 | 0.2% | 10.5% | ||
| Q2 25 | 0.3% | 10.6% | ||
| Q1 25 | 0.3% | 10.3% | ||
| Q4 24 | 0.2% | 12.4% | ||
| Q3 24 | 0.1% | 12.3% | ||
| Q2 24 | 0.1% | 10.1% | ||
| Q1 24 | 0.2% | 10.4% |
| Q4 25 | 0.74× | 51.58× | ||
| Q3 25 | 1.30× | — | ||
| Q2 25 | 2.74× | — | ||
| Q1 25 | 2.89× | — | ||
| Q4 24 | 1.31× | — | ||
| Q3 24 | 2.15× | — | ||
| Q2 24 | 3.23× | — | ||
| Q1 24 | 1.40× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMG
暂无分部数据
CLVT
| Academia Government Group | $312.3M | 51% |
| Re Occurring Revenues | $114.1M | 18% |
| Life Sciences And Healthcare Group | $98.3M | 16% |
| Transactional Revenues | $97.1M | 16% |
